This study utilizes the dual‐recombinase system‐driven genetic mouse model of spontaneous pancreatic cancer in combination with fluorescence‐switching reporters and mesenchymal fate mapping transgenes (αSMA‐Cre and Fsp1‐Cre), to lineage trace EMT program. The gene discussed is S100A4; the disease is pancreatic neoplasm.